🚨 Big shake-up in UK finance! The FCA has banned Howard Duckett, a senior manager at Beauforce, citing serious dishonesty and integrity issues. What does this mean for the industry? 🤔 $UKBTC #CryptoRegulations

$CRCL #GateStockInsightsChallenge
Circle Stock Rises 10%: Arc Mainnet and Strategic Moves Boost Market
Circle Internet Group (CRCL) shares closed Wednesday's regular trading session on Nasdaq up 9.65% at $78.62. The intraday high was $81.21 and the low was $73.69. Trading volume exceeded 22.9 million, nearly double the average daily volume. In after-hours trading, the stock climbed as high as $80.90.
The main driver of the rise was the increasing market expectation that Circle's Arc blockchain network will launch its mainnet on September 16th. Arc is positioned as an open blockchain network

#晒出我的合约收益# Why set a take-profit order? Seriously.

ETH leads the gains! XAU is keeping right in step!
ETH is currently continuing its sharp rebound, up 452 points!
XAU has posted a rebound of over 200 points!
Another day of consecutive wins after positioning in advance!
You actually don't need many trades—just make them precise. Capitalizing on a few opportunities a week or even a month is enough to cover your expenses for the year. Are you still waiting on the sidelines?
$ETH $XAU

Crazy what a candle like this will do for the vibes
$BTC

$HIMS
What appears to be a cup+handle in this area looks like a short W on the weekly chart

#GateEventPointsSystemLaunched
Gate Event Contracts: a simpler way to trade market direction
Gate Event Contracts introduce a different approach to crypto trading. Instead of using traditional leveraged futures with margin, liquidation risk and funding rates, the product focuses on one simple question:
Will the selected asset move up or down when the event period ends?
The concept is straightforward. Choose an asset, select the direction you expect, choose an available contract price and enter the amount you want to participate with.
Currently, Gate Event Contracts support BTC, ETH, SOL and X

Lets take a look at ethereum:native through $ETH A
Just closed the first gap, next one is in the mid $19s which means another +15% upside so I'd think we probably get a push to $2600 ethereum before hitting some resistance

I marked on the LINK chart where my trip started. This happens every time, I realize it's insane, I can't explain it

you know whats better than bitcoin:native?
BTC with 400% APR
ROI completed, now its time to enjoy the journey

I originally wanted to cut my losses as a sacrifice to the heavens, but the heavens weren't appeased—the meat cooked itself.🍖 When the market was just being dumped in the early session, I saw that $GENIUS had absolutely no volume to support its rebound. Every upward push looked like mere window dressing, with heavy resistance firmly capping it from above. Anyone with even a little experience could tell it was under pressure at high levels. When I saw the candlestick's center of gravity continuing to move lower, I knew what was going on: the biggest fear with high-level consolidation is a sudd

SOL surges ~11% in 24h; top price prints above $87 briefly, market cap around $50.4B. If sustained, could signal renewed demand for SOL custody and ecosystem activity. $SOL

$XAUUSD August 20, 2026 Gold Thursday Full Analysis
Yesterday brought joy to some and sorrow to others.
Wednesday's move was extremely strong. It opened above 4330, dipped as low as 4324, then rallied all the way up, reaching around 4506 at the high. It has now reached the 4510-4511 area, with the day's gain approaching 4%.
The driver was very clear: the FOMC minutes were broadly dovish, long-end yields fell, and short covering combined with long chasing erased the entire previous day's decline and created a new stage high. Bullish sentiment was clearly ignited after the minutes.
Morning Openi

It's good to fail early cause you gats to correct your mistake early.

JUST IN: Trump says CFTC Chair Selig working to bring Hyperliquid perpetual futures to U.S. under federal rules.
@HyperliquidX

$MRNA #GateStockInsightsChallenge
Moderna's mRNA Cancer Vaccine Achieves Historic Success
Moderna and Merck's personalized mRNA cancer vaccine, intismeran, has achieved success in Phase 3 clinical trials. This marks a first for an mRNA cancer vaccine to yield positive results in a large-scale late-stage trial.
The companies announced Wednesday that intismeran, in combination with Merck's immune checkpoint inhibitor Keytruda, significantly slowed cancer recurrence and spread to other parts of the body in patients with high-risk melanoma (skin cancer). The Phase 3 INTerpath-001 trial involved

BREAKING: Trump says US has discussed accumulating Bitcoin and other crypto on large scale.